In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae

Antimicrob Agents Chemother. 2019 Jul 25;63(8):e01048-19. doi: 10.1128/AAC.01048-19. Print 2019 Aug.

Authors

Stephan Kohlhoff¹, Natalia Huerta¹, Margaret R Hammerschlag²

Affiliations

¹ Department of Pediatrics, Division of Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, New York, USA.
² Department of Pediatrics, Division of Infectious Diseases, SUNY Downstate Medical Center, Brooklyn, New York, USA mhammerschlag@downstate.edu.

No abstract available

Keywords: Chlamydia pneumoniae; levonadifloxacin; quinolones.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use*
Chlamydia Infections / drug therapy*
Chlamydia Infections / microbiology
Chlamydophila pneumoniae / drug effects
Chlamydophila pneumoniae / pathogenicity
Fluoroquinolones / pharmacology*
Fluoroquinolones / therapeutic use*
Humans
Microbial Sensitivity Tests

Substances

Anti-Bacterial Agents
Fluoroquinolones
WCK 771